|
Unlocking New Pathways in Prostate Cancer Treatment: Join Our Comprehensive Masterclass Video Series, "Beyond Androgen Blockade"! This masterclass series was created to educate clinicians with advanced insights on key targets and pathways for personalized treatment approaches for patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).
|
|
|
|
|
|
Educational Video Series Masterclass
|
|
|
|
|
|
|
The Biological Basis of Metastatic Prostate Cancer – The Unmet Medical Need for New Targets and Novel Treatment Pathways
|
|
Dan George, MD
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Real World Evidence Evaluating the Underutilization of Treatments for mCRPC in Clinical Practice
|
|
Mark Fleming, MD
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| The Current Treatment Landscape in Metastatic Hormone-Sensitive Prostate Cancer |
|
Andrew Armstrong, MD
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bone Health Management for Advanced Prostate Cancer
|
|
Fred Saad, MD, FRSC
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
| Tumor Heterogeneity Selective Pressure – Why We Need New Targets? |
| A. Oliver Sartor, MD |
|
|
|
|
|
|
|
|
|
|
 |
|
| Unlocking Precision Care: Germline & Somatic Literacy in Prostate Cancer |
| Elisabeth Heath, MD, FACP |
|
|
|
|
|
|
|
|
|
|
|
|
Unlocking the Future of mCRPC Treatment: Exploring Immune Checkpoint Inhibitors for MMR Loss and MSI-High
|
| Sumit Subudhi, MD, Ph.D. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PARP Inhibitors: Targeting DNA Repair Pathways
|
|
Neal Shore, MD, FACS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AKT inhibitors – Targeting PI3K/AKT/MTOR Signaling Axis
|
|
Cora Sternberg, MD, FACP
|
|
|
|
|
|
|
|
|
|
|
|
|
The Critical Intersection of Androgen Receptor Pathways and Cell Cycle Regulation in Prostate Cancer Therapy
|
|
Rana R. McKay, MD
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Broadening Treatment Horizons with CDK4/6 Inhibitors from Breast to Prostate Cancer
|
|
Rana R. McKay, MD
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PSMA PET as a Biomarker for Advanced Prostate Cancer
|
|
A. Oliver Sartor, MD
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023 Key Learnings in mCRPC Treatments – Key Findings
|
|
Alicia Morgans, MD, MPH
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Treatment Decision Making in mHSPC: The Medical Oncologist and Patient “What the Patient Needs to Know” About this Disease and Treatment Options?
|
|
Brenda Martone, MSN, ANP-BC, AOCNP
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Treatment Decision Making in mCRPC: The Urologist and Patient “What the Patient Needs to Know” About His Disease and Treatment Options?
|
|
Brenda Martone, MSN, ANP-BC, AOCNP
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Multidisciplinary Approach in the Treatment of Metastatic Prostate Cancer
|
|
Robert Dreicer, MD, MS, MACP, FASCO
|
|
|
|
|
|
|
|
|
|
|
|
